Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229070879> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4229070879 endingPage "1852" @default.
- W4229070879 startingPage "1852" @default.
- W4229070879 abstract "Dear Editor, We read the article “Efficacy of low concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes”[1] published in January 2022 issue. We would like to congratulate the author for the successful randomized case control study. We have a few queries regarding the study, which are as follows: The inclusion Criteria states that patients with Spherical Equivalent < +1.00 were included. Would be interesting to note how many with and without Low concentration Atropine (LCA) needed glass prescription at the end of the study period? As age included is 4–12 years, was topography reliable/possible in all patients? Since only family history of pathological or high myopia was excluded, significant risk factor in terms of myopia from an early age in parents can induce bias and needs to be addressed.[2] LCA is well established in treating the progression of myopia, and 0.01% was chosen based on less rebound effects.[3] The article concludes with results at the end of 2 years, without mentioning if this is the phase 1 of the study. It would be interesting to note how long the effects last and the rebound effects if any. We were also curious to understand how the other risk factors in terms of outdoor activity, sunlight exposure, near activities, and vitamin D deficiency were standardized in both groups.[4] With online classes being the norm in post-COVID-19 era, children in age group of 9–12 years were at a risk of more hours of near activities versus younger children. Although the study has a small sample size, would be interesting to know the outcomes in these subgroups. While the above comments do not undermine the significance of LCA in preventing the onset of myopia in children at high risk for the same, addressing the impact of above-mentioned factors is imperative to establish the role of LCA in premyopes. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest." @default.
- W4229070879 created "2022-05-08" @default.
- W4229070879 creator A5020602579 @default.
- W4229070879 creator A5068082548 @default.
- W4229070879 date "2022-01-01" @default.
- W4229070879 modified "2023-09-25" @default.
- W4229070879 title "Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes" @default.
- W4229070879 cites W1584882878 @default.
- W4229070879 cites W2057383623 @default.
- W4229070879 cites W2061894232 @default.
- W4229070879 cites W4200103785 @default.
- W4229070879 doi "https://doi.org/10.4103/ijo.ijo_96_22" @default.
- W4229070879 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35502098" @default.
- W4229070879 hasPublicationYear "2022" @default.
- W4229070879 type Work @default.
- W4229070879 citedByCount "1" @default.
- W4229070879 countsByYear W42290708792022 @default.
- W4229070879 crossrefType "journal-article" @default.
- W4229070879 hasAuthorship W4229070879A5020602579 @default.
- W4229070879 hasAuthorship W4229070879A5068082548 @default.
- W4229070879 hasBestOaLocation W42290708791 @default.
- W4229070879 hasConcept C118487528 @default.
- W4229070879 hasConcept C126322002 @default.
- W4229070879 hasConcept C187212893 @default.
- W4229070879 hasConcept C2426938 @default.
- W4229070879 hasConcept C2775859210 @default.
- W4229070879 hasConcept C71924100 @default.
- W4229070879 hasConcept C98274493 @default.
- W4229070879 hasConceptScore W4229070879C118487528 @default.
- W4229070879 hasConceptScore W4229070879C126322002 @default.
- W4229070879 hasConceptScore W4229070879C187212893 @default.
- W4229070879 hasConceptScore W4229070879C2426938 @default.
- W4229070879 hasConceptScore W4229070879C2775859210 @default.
- W4229070879 hasConceptScore W4229070879C71924100 @default.
- W4229070879 hasConceptScore W4229070879C98274493 @default.
- W4229070879 hasIssue "5" @default.
- W4229070879 hasLocation W42290708791 @default.
- W4229070879 hasLocation W42290708792 @default.
- W4229070879 hasLocation W42290708793 @default.
- W4229070879 hasLocation W42290708794 @default.
- W4229070879 hasOpenAccess W4229070879 @default.
- W4229070879 hasPrimaryLocation W42290708791 @default.
- W4229070879 hasRelatedWork W1966752643 @default.
- W4229070879 hasRelatedWork W1982822494 @default.
- W4229070879 hasRelatedWork W2127691783 @default.
- W4229070879 hasRelatedWork W2161713508 @default.
- W4229070879 hasRelatedWork W2409957712 @default.
- W4229070879 hasRelatedWork W2410491650 @default.
- W4229070879 hasRelatedWork W2604682584 @default.
- W4229070879 hasRelatedWork W2767322544 @default.
- W4229070879 hasRelatedWork W3097643076 @default.
- W4229070879 hasRelatedWork W4224239504 @default.
- W4229070879 hasVolume "70" @default.
- W4229070879 isParatext "false" @default.
- W4229070879 isRetracted "false" @default.
- W4229070879 workType "article" @default.